Translational Medicine

New Biomarker Assays at QPS Are Paving the Way for Personlized medicine - February, 2014

The following biomarker assays have recently been added to the QPS Global Assay Database:

New Biomarker Assays Surrogate Endpoint
β2-microglobulin (B2M) – Human Serum & Urine Kidney function
CD40 (soluble) Atherosclerosis
c-Met / Hepatocyte Growth Factor Receptor 1 (HGF-R1) Activation of c-MET/HGF pathway in cancer cells
Collagen IV Liver injury
Cystatin C – Human Serum & Urine Kidney function
ICAM1 Atherosclerosis
MT-RNR1 [1555A>G] and MT-TS1 [3243A>G] Mitochondrial DNA Genotyping Predisposition to aminoglycoside ototoxicity and/or late-onset sensorineural hearing loss

Search the complete listing of our assays with the online QPS Assay Finder, or get the free QPS Assay Finder App from iTunes or the Google Play Store.

20 years in pharma R&D navigation